Richard Scott Struthers
CIK 1746298 · President & CEO · last filed 2026-09-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CRNX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6055 LUSK BOULEVARD
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | President & CEO | 0 | $84.95 | $0 | -$23.12M | 37 | 2026-09-01 |
Recent Filings · Page 2 of 5
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-04 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Exer (M) | +81,270 | $155.2K | EDGAR |
| 2025-03-21 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Sell (S) | −17,338 | -$593.0K | EDGAR |
| 2025-02-24 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Grant (A) | +89,000 | $0 | EDGAR |
| 2024-12-04 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Sell (S) | −10,000 | -$575.7K | EDGAR |
| 2024-12-02 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Notice (144) | −10,000 | -$572.7K | EDGAR |
| 2024-05-10 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Mixed | — | -$4.31M | EDGAR |
| 2024-05-08 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Notice (144) | −107,448 | -$5.31M | EDGAR |
| 2024-04-22 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Gift (G) | −350 | $0 | EDGAR |
| 2024-04-17 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Exer (M) | +20,000 | $38.2K | EDGAR |
| 2024-04-08 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Mixed | — | -$1.63M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.